Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Long-term follow-up results of nonremission relapsed/refractory DLBCL with CAR T-cell cocktail therapy alone or in combination with ASCT

Xiaoying Zhang, Jue Wang, Na Wang, Jia Wei, Yang Cao, Yicheng Zhang

Blood (2025) 146 (Supplement 1): 7243.

https://doi.org/10.1182/blood-2025-7243

Published: 2025

Journal Articles

First-in-human Phase I study of autologous CD5-knockout anti-CD5 CAR-T cells in CD5⁺ hematologic malignancies

Jiali Cheng, Li Zhu, Jia Wu, Yuhan Zeng, Xia Mao, Jue Wang, Liang Huang, Yi Xiao, Xiaoxi Zhou, Wei Mu, Xiaojian Zhu

Blood (2025) 146 (Supplement 1): 5949.

https://doi.org/10.1182/blood-2025-5949

Published: 2025

Journal Articles

Long-term follow-up reveals sustained benefit of dual CD19/CD22 CAR T-cell therapy alone or combined with autologous stem cell transplantation in TP53-altered relapsed/refractory B-cell non-Hodgkin lymphoma

Juan Peng, Zekai Mao, Yang Cao, Na Wang, Jue Wang, Yang Yang, Jinghuan Xu, Fankai Meng, Liting Chen, Xia Mao, Jiaqi Guo, Xiaoxi Zhou, Yicheng Zhang, Jia Wei

Blood (2025) 146 (Supplement 1): 3712.

https://doi.org/10.1182/blood-2025-3712

Published: 2025

Journal Articles

The total blood n-glycome landscape of hematological malignancies

Yueyi Xu, Jue Wang, Junli Zhang, Cuiying Chen, Huang Hongming, Xiaofeng Shi, Xuejun Zhu, Xuezhong Zhang, Jinning Shi, Xiaogang Zhou, Jiahua Ding, Bing Chen, Jian Ouyang

Blood (2025) 146 (Supplement 1): 391.

https://doi.org/10.1182/blood-2025-391

Published: 2025

Journal Articles

CD44v6 promotes anti-apoptotic phenotypes in AML via an SPP1-mediated autocrine activation of the MAPK-dusp pathway

Jia Wu, Xiaoya Cai, Ying Liu, Yeming Zhou, Bingxin Qian, Mei Huang, Jue Wang, Dengju Li

Blood (2025) 146 (Supplement 1): 7019.

https://doi.org/10.1182/blood-2025-7019

Published: 2025

Journal Articles

Survival prediction in relapsed/refractory B-cell lymphoma treated with CAR-T therapy: An AI-optimized cox regression model based on CCL5, scgf-β, and TRAIL

Hu Qian, Zekai Mao, Anqi Zhang, Xiaoying Zhang, Xingcheng Yang, Juan Peng, Jiaqi Guo, Liting Chen, Hui Luo, Li Zhu, Xiaoxi Zhou, Yang Yang, Na Wang, Jue Wang, Yicheng Zhang, Jia Wei

Blood (2025) 146 (Supplement 1): 4115.

https://doi.org/10.1182/blood-2025-4115

Published: 2025

Journal Articles

Multi-omics unveils ER stress-driven pDC-like leukemia stem cells in pDC-AML

Xingcheng Yang, Juan Peng, Ling Ma, Lei Zhang, Yicheng Zhang, Xia Mao, Jue Wang, Jia Wei

Blood (2025) 146 (Supplement 1): 1693.

https://doi.org/10.1182/blood-2025-1693

Published: 2025

Journal Articles

Pola-Based Framework Regimen Treating DLBCL in Real World at Renji Hospital of China

Jun Du, Jue Wang, Zi-Yu Feng, Lan Xu, Fei Xiao, Jia Liu, Dan Xiao, Wan-Bin Fu, Min-Yue Zhang, Li-Jing Shen, Lu Zhong, Hua Zhong, Jian Hou, Hong-Hui Huang, Ting Wang

Blood (2024) 144 (Supplement 1): 7729.

https://doi.org/10.1182/blood-2024-206799

Published: 2024

Journal Articles

Improving CAR-T Cell Function through a Targeted Cytokine Delivery System Utilizing CAR Target-Modified Extracellular Vesicles

Yuanyuan Zhang, Meijuan Huang, Tianjiao Liu, Yuhang Cheng, Dengju Li, Yang Cao, Wei Mu, Liting Chen, Li Zhu, Tongjuan Li, Liang Huang, Jia Wei, Lei Zhao, Jue Wang

Blood (2024) 144 (Supplement 1): 3419.

https://doi.org/10.1182/blood-2024-206731

Published: 2024

Journal Articles

A Case of Proliferative Glomerulonephritis with Monoclonal Kappa-Light Chain Deposits Treated with Daratumumab Combination Therapy

Jun Du, Jue Wang, JunTing Lv, Dan Xiao, Jia Liu, Lu Zhong

Blood (2024) 144 (Supplement 1): 6886.

https://doi.org/10.1182/blood-2024-206837

Published: 2024

Journal Articles

Superiority in the Longer Duration of Response and Better Central Nervous System Penetration of CAR-T Cell Therapy over Blinatumomab Infusion for Relapsed/ Refractory B-Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis

Yuhang Cheng, Xueyan Sun, Meijuan Huang, Lei Zhao, Jue Wang, Hanyu Wang, Wanying Liu, Shanwei Ye, Liang Huang, Gaoxiang Wang, Yang Cao

Blood (2024) 144 (Supplement 1): 1447.

https://doi.org/10.1182/blood-2024-207442

Published: 2024

Journal Articles

Type I Interferon Impairs the Function of CAR-T Cells By Disrupting Immune Synapse Assembly

Meijuan Huang, Lei Zhao, Yuhang Cheng, Liang Huang, Jianfeng Zhou, Dengju Li, Jue Wang, Yang Cao

Blood (2024) 144 (Supplement 1): 3407.

https://doi.org/10.1182/blood-2024-197968

Published: 2024

Journal Articles

Targeted-Delivery Strategy of Engineered EV Functionalized By Anti-CD3/CD19 Bi-Specific T-Cell Engager in Treating B-Cell Malignancies

Xiuiu Yang, Shanwei Ye, Qian Xu, Jue Wang, Caroline Markmann, Lingfeng Zhang, Shujia Zhang, Xinyue Deng, Jiali Cheng, Jia Wu, Vijay Bhoj, Zheng Zhang, Liang Huang

Blood (2024) 144 (Supplement 1): 89.

https://doi.org/10.1182/blood-2024-210125

Published: 2024

Journal Articles

Proteomics and Single-Cell Transcriptomics Reveal Differentiation Patterns of pDC-like LSCs and Poor Prognosis in AML with pDC Expansion

Xingcheng Yang, Juan Peng, Lei Zhang, Yicheng Zhang, Xia Mao, Jue Wang, Jia Wei

Blood (2024) 144 (Supplement 1): 2935.

https://doi.org/10.1182/blood-2024-202707

Published: 2024

Journal Articles

Evi1 Governs Kdm6b-Mediated Histone Demethylation to Regulate the Laptm4b-Driven mTOR Pathway in Hematopoietic Progenitor Cells

Qiong Wu, Chunjie Yu, Fang Yu, Yiran Guo, Yue Sheng, Liping Li, Yafang Li, Yutao Zhang, Chao Hu, Jue Wang, Tong-Chuan He, Yong Huang, Hongyu Ni, Zhigang Hou, Wenshu Wu, Greg G Wang, Jianxin Lyu, Zhijian Qian

Blood (2024) 144 (Supplement 1): 1337.

https://doi.org/10.1182/blood-2024-206390

Published: 2024

Journal Articles

Heterogeneity and Differentiation Patterns of pDC Cells in pDC-AML: A Novel Perspective from Single-Cell RNA Sequencing

Xingcheng Yang, Juan Peng, Chunrui Li, Yicheng Zhang, Xia Mao, Jue Wang, Jia Wei

Blood (2023) 142 (Supplement 1): 1568.

https://doi.org/10.1182/blood-2023-190826

Published: 2023

Journal Articles

Targeted Delivery of IL-12 Via CD19-Modified Extracellular Vesicles Enhances CAR-T Cell Efficacy Against Lymphoma

Meijuan Huang, Lei Zhao, Dengju Li, Liang Huang, Jue Wang, Yuanyuan Zhang

Blood (2023) 142 (Supplement 1): 6798.

https://doi.org/10.1182/blood-2023-180860

Published: 2023

Journal Articles

Phase 1 Dose Escalation Study of the Anti-CD7 CAR-T Therapy in Relapsed/Refractory T-Cell Acute Leukemia and Lymphoblastic Lymphoma

Jiali Cheng, Jue Wang, Xia Mao, Wei Mu, Shijia Sun, Xiaoxi Zhou, Liang Huang

Blood (2023) 142 (Supplement 1): 6863.

https://doi.org/10.1182/blood-2023-184370

Published: 2023

Journal Articles

Functional Diversification and Dynamics of CAR-T Cells in B-ALL Patients

Blood (2023) 142 (Supplement 1): 4851.

https://doi.org/10.1182/blood-2023-178624

Published: 2023

Journal Articles

CD19/CD22 CAR T-Cell Therapy Following Autologous Transplantation Is an Optimizing Strategy in Relapsed/Refractory Central Nervous System Lymphoma

Qiuxia Yu, Daizi Gang, Jue Wang, Liang Huang, Chunrui Li, Yicheng Zhang, Xiaoxi Zhou, Yang Cao

Blood (2023) 142 (Supplement 1): 6855.

https://doi.org/10.1182/blood-2023-180363

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Long-term follow-up results of nonremission relapsed/refractory DLBCL with CAR T-cell cocktail therapy alone or in combination with ASCT

First-in-human Phase I study of autologous CD5-knockout anti-CD5 CAR-T cells in CD5⁺ hematologic malignancies

Long-term follow-up reveals sustained benefit of dual CD19/CD22 CAR T-cell therapy alone or combined with autologous stem cell transplantation in TP53-altered relapsed/refractory B-cell non-Hodgkin lymphoma

The total blood n-glycome landscape of hematological malignancies

CD44v6 promotes anti-apoptotic phenotypes in AML via an SPP1-mediated autocrine activation of the MAPK-dusp pathway

Survival prediction in relapsed/refractory B-cell lymphoma treated with CAR-T therapy: An AI-optimized cox regression model based on CCL5, scgf-β, and TRAIL

Multi-omics unveils ER stress-driven pDC-like leukemia stem cells in pDC-AML

Pola-Based Framework Regimen Treating DLBCL in Real World at Renji Hospital of China

Improving CAR-T Cell Function through a Targeted Cytokine Delivery System Utilizing CAR Target-Modified Extracellular Vesicles

A Case of Proliferative Glomerulonephritis with Monoclonal Kappa-Light Chain Deposits Treated with Daratumumab Combination Therapy

Superiority in the Longer Duration of Response and Better Central Nervous System Penetration of CAR-T Cell Therapy over Blinatumomab Infusion for Relapsed/ Refractory B-Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis

Type I Interferon Impairs the Function of CAR-T Cells By Disrupting Immune Synapse Assembly

Targeted-Delivery Strategy of Engineered EV Functionalized By Anti-CD3/CD19 Bi-Specific T-Cell Engager in Treating B-Cell Malignancies

Proteomics and Single-Cell Transcriptomics Reveal Differentiation Patterns of pDC-like LSCs and Poor Prognosis in AML with pDC Expansion

Evi1 Governs Kdm6b-Mediated Histone Demethylation to Regulate the Laptm4b-Driven mTOR Pathway in Hematopoietic Progenitor Cells

Heterogeneity and Differentiation Patterns of pDC Cells in pDC-AML: A Novel Perspective from Single-Cell RNA Sequencing

Targeted Delivery of IL-12 Via CD19-Modified Extracellular Vesicles Enhances CAR-T Cell Efficacy Against Lymphoma

Phase 1 Dose Escalation Study of the Anti-CD7 CAR-T Therapy in Relapsed/Refractory T-Cell Acute Leukemia and Lymphoblastic Lymphoma

Functional Diversification and Dynamics of CAR-T Cells in B-ALL Patients

CD19/CD22 CAR T-Cell Therapy Following Autologous Transplantation Is an Optimizing Strategy in Relapsed/Refractory Central Nervous System Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only